1. Home
  2. CYTK vs FRSH Comparison

CYTK vs FRSH Comparison

Compare CYTK & FRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • FRSH
  • Stock Information
  • Founded
  • CYTK 1997
  • FRSH 2010
  • Country
  • CYTK United States
  • FRSH United States
  • Employees
  • CYTK N/A
  • FRSH N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • FRSH EDP Services
  • Sector
  • CYTK Health Care
  • FRSH Technology
  • Exchange
  • CYTK Nasdaq
  • FRSH Nasdaq
  • Market Cap
  • CYTK 4.6B
  • FRSH 3.7B
  • IPO Year
  • CYTK 2004
  • FRSH 2021
  • Fundamental
  • Price
  • CYTK $60.16
  • FRSH $11.19
  • Analyst Decision
  • CYTK Strong Buy
  • FRSH Buy
  • Analyst Count
  • CYTK 15
  • FRSH 16
  • Target Price
  • CYTK $76.73
  • FRSH $19.44
  • AVG Volume (30 Days)
  • CYTK 1.7M
  • FRSH 3.7M
  • Earning Date
  • CYTK 11-05-2025
  • FRSH 11-05-2025
  • Dividend Yield
  • CYTK N/A
  • FRSH N/A
  • EPS Growth
  • CYTK N/A
  • FRSH N/A
  • EPS
  • CYTK N/A
  • FRSH N/A
  • Revenue
  • CYTK $87,211,000.00
  • FRSH $810,640,000.00
  • Revenue This Year
  • CYTK $363.61
  • FRSH $17.01
  • Revenue Next Year
  • CYTK $64.33
  • FRSH $13.02
  • P/E Ratio
  • CYTK N/A
  • FRSH N/A
  • Revenue Growth
  • CYTK 2609.26
  • FRSH 18.18
  • 52 Week Low
  • CYTK $29.31
  • FRSH $10.51
  • 52 Week High
  • CYTK $64.13
  • FRSH $19.77
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 55.21
  • FRSH 42.16
  • Support Level
  • CYTK $58.05
  • FRSH $10.52
  • Resistance Level
  • CYTK $61.29
  • FRSH $11.31
  • Average True Range (ATR)
  • CYTK 2.60
  • FRSH 0.34
  • MACD
  • CYTK -0.48
  • FRSH 0.03
  • Stochastic Oscillator
  • CYTK 57.88
  • FRSH 46.05

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

Share on Social Networks: